Literature DB >> 19517245

The contribution of serotonin 1A receptors to kappa opioid immunosuppression.

M A Cheido1, G V Idova.   

Abstract

Activation of kappa opioid receptors (kappa-OR) with the selective agonist rimorphin (0.1 mg/kg) produced marked suppression of the immune response in CBA mice. This effect was not seen on administration of rimorphin on the background of a reduction in the activity of the serotoninergic (5-HTergic) system resulting from stimulation of presynaptic (8-OH-DPAT, 0.1 mg/kg) or blockade of postsynaptic (WAY-100635, 1.0 mg/kg) 5-HT1A receptors. These data led to the conclusion that 5-HTergic mechanisms involving preand postsynaptic 5-HT1A receptors have a role in kappa-opioid-mediated immunosuppression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19517245     DOI: 10.1007/s11055-009-9169-8

Source DB:  PubMed          Journal:  Neurosci Behav Physiol        ISSN: 0097-0549


  38 in total

1.  Presynaptic opioid receptors on noradrenergic and serotonergic neurons in the human as compared to the rat neocortex.

Authors:  Benjamin Berger; Anna Katharina Rothmaier; Franziska Wedekind; Josef Zentner; Thomas J Feuerstein; Rolf Jackisch
Journal:  Br J Pharmacol       Date:  2006-06-05       Impact factor: 8.739

2.  5-HT agonist-induced changes in peripheral immune cells in healthy volunteers: the impact of personality.

Authors:  J Hennig; H Becker; P Netter
Journal:  Behav Brain Res       Date:  1996       Impact factor: 3.332

3.  A method of increased sensitivity for detecting single antibody-forming cells.

Authors:  A J Cunningham
Journal:  Nature       Date:  1965-09-04       Impact factor: 49.962

4.  Serotonin involvement in the discriminative stimulus effects of mu and kappa opioids in rats.

Authors:  K.R. Powell; M.J. Picker; L.A. Dykstra
Journal:  Behav Pharmacol       Date:  1994-06       Impact factor: 2.293

5.  5-HT1A receptors are differentially involved in the anxiolytic- and antidepressant-like effects of 8-OH-DPAT and fluoxetine in the rat.

Authors:  J De Vry; R Schreiber; C Melon; M Dalmus; K R Jentzsch
Journal:  Eur Neuropsychopharmacol       Date:  2004-12       Impact factor: 4.600

6.  Depressive-like effects of the kappa-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats.

Authors:  William A Carlezon; Cécile Béguin; Jennifer A DiNieri; Michael H Baumann; Michele R Richards; Mark S Todtenkopf; Richard B Rothman; Zhongze Ma; David Y-W Lee; Bruce M Cohen
Journal:  J Pharmacol Exp Ther       Date:  2005-10-13       Impact factor: 4.030

7.  Central monoaminergic mechanisms in mice and analgesic activity of spiradoline mesylate, a selective kappa-opioid receptor agonist.

Authors:  M Kunihara; M Ohyama; M Nakano
Journal:  Eur J Pharmacol       Date:  1992-04-22       Impact factor: 4.432

8.  The modulatory effects of mu and kappa opioid agonists on 5-HT release from hippocampal and hypothalamic slices of euthermic and hibernating ground squirrels.

Authors:  Y Cui; T F Lee; L I Kramarova; L C Wang
Journal:  Life Sci       Date:  1993       Impact factor: 5.037

9.  Opposing activities of brain opioid receptors in the regulation of humoral and cell-mediated immune responses in the rat.

Authors:  J Radulović; B D Janković
Journal:  Brain Res       Date:  1994-10-24       Impact factor: 3.252

10.  Distribution of mu, delta, and kappa opioid receptors in the hypothalamus of the rat.

Authors:  G C Desjardins; J R Brawer; A Beaudet
Journal:  Brain Res       Date:  1990-12-17       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.